What We Offer

Our services are designed to accelerate your cancer research and drug development.

1. Preclinical Pharmacology Studies (PD/PK, Acute Toxicology)

Vivarium & In vivo Pharmacology Program

Two dedicated animal rooms with IVC racks. Subcutaneous and orthotopic human tumor mouse models including PDOX, metastasis, recurrence, PK/PD, and acute toxicology.

2. Dual Humanized Tumor and Immune System Xenograft Tumor Models Study

Primarily applied in the study of tumor-immune interactions and the development and evaluation of immunotherapies, offering higher clinical relevance for preclinical testing.

3. Advanced Imaging & Tumor Visualization Models Study

Enable real-time, non-invasive monitoring of tumor growth and treatment response in orthotopic tumor models, enhancing the efficiency and accuracy of in vivo drug efficacy assessments.

4. Metastatic Cancer Mouse Models Study

Designed to explore the mechanisms of cancer metastasis and provide foundational models for the development and evaluation of anti-metastatic therapies.

5. Personalized Precision Cancer Treatment Studies

Support the development of personalized cancer treatment strategies based on individual tumor characteristics, and facilitate research on tumor heterogeneity and drug resistance.

6. EchoMRI-Based Metabolic Disease Research

The EchoMRI system offers rapid, repeatable, and anesthesia-free measurements of fat mass, lean mass, and body water in small animals. As a globally recognized tool in metabolic phenotyping, it plays a crucial role in evaluating the progression of metabolic disorders and the efficacy of therapeutic interventions.

7. Histopathology Study

At VivoxBio, our Histopathology Division provides comprehensive, expert-driven tissue processing, analysis, and interpretation services to support and accelerate your drug development programs. From necropsy to digital pathology, we offer end-to-end solutions tailored to your research needs. Learn More

Why VivoxBio

  • Clinical relevance of PDOX/PDX tumor models
  • Proprietary CQD tracers (OncoReveal™) for real-time tracking
  • OncoExo™ exosome platform for personalized studies
  • High-throughput imaging workflow and rapid turnaround
  • AAALAC-ready animal facility + strict confidentiality/IP protection
Rapid In Vivo Screening
  • 3–5 mice/group; 2–3 dose levels
  • Imaging endpoints for candidate triage
  • Typical turnaround: 3–4 weeks

What Our Clients Say

Interested in our services?

Contact us to discuss how we can support your research needs.